SLAMF7-directed Immunostimulatory Antibody class drugs

FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

1 result

Empliciti (elotuzumab)

(elotuzumab)

Manufacturer:E.R. Squibb & Sons, L.L.C.

Usage: EMPLICITI is indicated for treating adult patients with multiple myeloma in combination with lenalidomide and dexamethasone after one to three prior therapies, or with pomalidomide and dexamethasone after at least two prior therapies, including lenalidomide and a proteasome inhibitor.